Glenda C. Webb

611 total citations
8 papers, 455 citations indexed

About

Glenda C. Webb is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Glenda C. Webb has authored 8 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Glenda C. Webb's work include Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotic Resistance in Bacteria (2 papers) and Antimicrobial Peptides and Activities (2 papers). Glenda C. Webb is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotic Resistance in Bacteria (2 papers) and Antimicrobial Peptides and Activities (2 papers). Glenda C. Webb collaborates with scholars based in United States. Glenda C. Webb's co-authors include Barbara D. Foleno, Mark J. Macielag, John F. Barrett, Dennis J. Hlasta, Stephanie A. Fraga‐Spano, Harvey M. Werblood, Michele A. Weidner‐Wells, Karen Bush, Zhihua Sui and Kwasi A. Ohemeng and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Glenda C. Webb

8 papers receiving 432 citations

Peers

Glenda C. Webb
Kelly S.E. Tanaka United States
C. Dini France
John N. Alumasa United States
Jeremiah S. Helm United States
Jason L. Bowman United States
Miha Kotnik Slovenia
Harvey M. Werblood United States
Kelly S.E. Tanaka United States
Glenda C. Webb
Citations per year, relative to Glenda C. Webb Glenda C. Webb (= 1×) peers Kelly S.E. Tanaka

Countries citing papers authored by Glenda C. Webb

Since Specialization
Citations

This map shows the geographic impact of Glenda C. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenda C. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenda C. Webb more than expected).

Fields of papers citing papers by Glenda C. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenda C. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenda C. Webb. The network helps show where Glenda C. Webb may publish in the future.

Co-authorship network of co-authors of Glenda C. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Glenda C. Webb. A scholar is included among the top collaborators of Glenda C. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenda C. Webb. Glenda C. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Foleno, Barbara D., Darren Abbanat, Raúl Goldschmidt, et al.. (2006). In Vitro Antibacterial Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457. Antimicrobial Agents and Chemotherapy. 51(1). 361–365. 18 indexed citations
2.
Abbanat, Darren, et al.. (2004). In Vitro Activities of Novel 2-Fluoro-Naphthyridine-Containing Ketolides. Antimicrobial Agents and Chemotherapy. 49(1). 309–315. 7 indexed citations
3.
Weidner‐Wells, Michele A., Kwasi A. Ohemeng, Van N. Nguyen, et al.. (2001). Amidino benzimidazole inhibitors of bacterial two-component systems. Bioorganic & Medicinal Chemistry Letters. 11(12). 1545–1548. 111 indexed citations
4.
Baum, Ellen Z., et al.. (2001). Identification and Characterization of New Inhibitors of the Escherichia coli MurA Enzyme. Antimicrobial Agents and Chemotherapy. 45(11). 3182–3188. 96 indexed citations
5.
Kanojia, Ramesh M., William V. Murray, Jeffrey I. Bernstein, et al.. (1999). 6-Oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems. Bioorganic & Medicinal Chemistry Letters. 9(20). 2947–2952. 13 indexed citations
6.
Sui, Zhihua, Dennis J. Hlasta, Mark J. Macielag, et al.. (1998). SAR studies of diaryltriazoles against bacterial two-component regulatory systems and their antibacterial activities. Bioorganic & Medicinal Chemistry Letters. 8(14). 1929–1934. 43 indexed citations
7.
Hlasta, Dennis J., James P. Demers, Barbara D. Foleno, et al.. (1998). Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: Pharmacophore identification based on the screening hit closantel. Bioorganic & Medicinal Chemistry Letters. 8(14). 1923–1928. 56 indexed citations
8.
Macielag, Mark J., James P. Demers, Stephanie A. Fraga‐Spano, et al.. (1998). Substituted Salicylanilides as Inhibitors of Two-Component Regulatory Systems in Bacteria. Journal of Medicinal Chemistry. 41(16). 2939–2945. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026